Talks

Understanding and Personalizing Immunotherapy Through Single-cell Analysis

Ben Izar, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute, talks about how multiplexed immunofluorescence imaging using t-CyCIF is revealing the architecture of tumors and the many types of cells involved. t-CyCIF (Tissue-based cyclic immunofluorescence) can be used to quantify signal transduction cascades, measure the levels of tumor antigens and determine immunophenotypes using immune cell lineage markers. t-CyCIF is a powerful tool to study drug resistance of immunotherapy in different patients.

Multiplexed Technologies for Spatial Analysis of FFPE Tumor Samples

Developing a Cloud Data Resource to Accelerate TB Research

Tissue Atlas Industry Showcases

HMS Tissue Atlas Program Industry Showcase, May 17, 2019

HMS Tissue Atlas Program Industry Showcase, July 18, 2019

HMS Tissue Atlas Program Industry Showcase, November 7, 2019